Chemoinformaics analysis of ALPHA-HYDROXYBEHENIC-ACID
| Molecular Weight | 198.174 | nRot | 3 |
| Heavy Atom Molecular Weight | 188.094 | nRig | 7 |
| Exact Molecular Weight | 198.053 | nRing | 1 |
| Solubility: LogS | -0.374 | nHRing | 0 |
| Solubility: LogP | -0.401 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 25.7079 |
| nHD | 4 | BPOL | 10.9001 |
| QED | 0.388 |
| Synth | 2.487 |
| Natural Product Likeliness | 0.632 |
| NR-PPAR-gamma | 0.037 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.939 |
| HIA | 0.024 |
| CACO-2 | -5.164 |
| MDCK | 0.000265293 |
| BBB | 0.159 |
| PPB | 0.523912 |
| VDSS | 1.248 |
| FU | 0.605103 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.078 |
| CYP2c19-inh | 0.03 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.026 |
| CYP2c9-sub | 0.631 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.268 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.096 |
| CL | 5.461 |
| T12 | 0.944 |
| hERG | 0.016 |
| Ames | 0.713 |
| ROA | 0.327 |
| SkinSen | 0.916 |
| Carcinogencity | 0.257 |
| EI | 0.924 |
| Respiratory | 0.268 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.89179 |